Cancer therapy using natural ligands that target estrogen receptor beta

Research output: Contribution to journalReview articlepeer-review

32 Scopus citations


Estrogen receptor beta (ERβ) is one of the two key receptors (ERα, ERβ) that facilitate biological actions of 17β-estradiol (E2). ERβ is widely expressed in many tissues, and its expression is reduced or lost during progression of many tumors. ERβ facilitates estrogen signaling by both genomic (classical and non-classical) and extra-nuclear signaling. Emerging evidence suggests that ERβ functions as a tissue-specific tumor suppressor with anti-proliferative actions. Recent studies have identified a number of naturally available selective ERβ agonists. Targeting ERβ using its naturally available ligands is an attractive approach for treating and preventing cancers. This review presents the beneficial actions of ERβ signaling and clinical utility of several natural ERβ ligands as potential cancer therapy.

Original languageEnglish (US)
Pages (from-to)801-807
Number of pages7
JournalChinese Journal of Natural Medicines
Issue number11
StatePublished - Nov 1 2015


  • ER beta agonists
  • Estrogen receptor
  • Estrogen receptor beta
  • Genistein
  • Liquiritigenin
  • S-equol
  • Tumor suppressor

ASJC Scopus subject areas

  • Drug Discovery
  • Complementary and alternative medicine


Dive into the research topics of 'Cancer therapy using natural ligands that target estrogen receptor beta'. Together they form a unique fingerprint.

Cite this